Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

103.39 +0.72 (+0.71%)

Streaming Delayed Price Updated: 1:06 PM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

54 55 Next >

Why Cardiovascular Systems Stock Is Soaring Today ↗

February 09, 2023

The medtech company has agreed to a buyout offer from Abbott Laboratories.

Via The Motley Fool

Cardiovascular Systems (NASDAQ: CSII) Enters Into Agreement to be Acquired By Abbott Labs (NYSE: ABT) For $890 Million

February 09, 2023

Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and

Via Spotlight Growth

Why Is Cardiovascular Systems (CSII) Stock Up 48% Today? ↗

February 09, 2023

Cardiovascular Systems (CSII) stock is rising higher on Thursday following news that Abbott (ABT) intends to acquire the company.

Via InvestorPlace

Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M ↗

February 09, 2023

Via Benzinga

3 Dividend Stocks That Will Hold Up No Matter the Market Conditions ↗

February 08, 2023

These stocks could boost your portfolio in bear markets and bull markets.

Via The Motley Fool

Is This Dividend King a Buy for Income Investors? ↗

February 07, 2023

This healthcare company has one of the most established payouts in its sector.

Via The Motley Fool

What 5 Analyst Ratings Have To Say About Abbott Laboratories ↗

January 26, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

January 25, 2023

Via Benzinga

Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023? ↗

February 07, 2023

The healthcare stock fell 22% last year.

Via The Motley Fool

2 Beaten-Down Stocks With Stable Dividends to Buy In 2023 ↗

February 04, 2023

You can bet the farm on these companies' dividends.

Via The Motley Fool

3 Unstoppable Dividend Stocks to Buy in February ↗

February 04, 2023

All three belong to the elite group of stocks known as Dividend Kings.

Via The Motley Fool

2 Top Dividend Growth Stocks to Buy in February ↗

February 01, 2023

They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.

Via The Motley Fool

5 Top Stocks to Buy Now ↗

January 31, 2023

This eclectic mix of stocks will help diversify your portfolio.

Via The Motley Fool

What's Going On With Abbott Laboratories Stock Today? ↗

January 25, 2023

Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results.

Via Benzinga

Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth ↗

January 25, 2023

Overall sales topped forecasts, but organic growth missed expectations.

Via Investor's Business Daily

Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗

January 30, 2023

Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.

Via Talk Markets

GE Healthcare Technology: Speculating On Dividends

January 30, 2023

GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one.

Via MarketBeat

Is Abbott Laboratories a Good Dividend Stock to Buy Now? ↗

January 28, 2023

At least four Wall Street banks recently raised their price targets for the healthcare giant.

Via The Motley Fool

Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review ↗

January 27, 2023

Stocks reacted well to uneven earnings and economic reports.

Via Investor's Business Daily

NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday ↗

January 26, 2023

Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on...

Via Benzinga

Abbott's Sales and Earnings Are Sinking: Should Investors Worry? ↗

January 26, 2023

There's more to the story than the negative trends for Abbott's top and bottom lines.

Via The Motley Fool

Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?

January 26, 2023

Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again.

Via MarketBeat

Topics Economy

Why Abbott Laboratories Stock Got Whacked on Wednesday ↗

January 25, 2023

Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day.

Via The Motley Fool

Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript ↗

January 25, 2023

ABT earnings call for the period ending December 31, 2022.

Via The Motley Fool

Why Aurora Cannabis Stock Is Fading Today ↗

January 25, 2023

With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.

Via The Motley Fool

Abbott Q4 Earnings And Revenues Top Estimates ↗

January 25, 2023

Abbott came out with quarterly earnings of $1.03 per share.

Via Talk Markets

Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower ↗

January 25, 2023

(Wednesday Market Open) The market gives and the market takes away.

Via Benzinga

Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February ↗

January 25, 2023

U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading:

Via Benzinga

Earnings Scheduled For January 25, 2023 ↗

January 25, 2023

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion.

Via Benzinga

Investor Optimism Declines Following Earnings Reports ↗

January 25, 2023

The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings.

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

54 55 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.